TRAIL-mediated armA upregulation enhances the drug resistance of Klebsiella pneumoniae by activating the PI3K/AKT/mTOR signaling pathway
Authors:
- 1 January 2025
- journal article
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 17 (8) , 6103-6112
Abstract
Objective: This study aimed to investigate the roles and mechanisms of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in the drug resistance of Klebsiella pneumoniae, focusing on its regulation of the aminoglycoside resistance methylase (armA) and the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway. Methods: A549 cells were infected with drug-resistant Klebsiella pneumoniae and treated with meropenem. TRAIL overexpression and knockdown were performed using plasmids and small interfering RNA, respectively. Cell viability, apoptosis, and the levels of inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) were assessed. The mRNA expression of armA was examined using reverse transcription quantitative polymerase chain reaction (RT-qPCR). The expression of key proteins in the PI3K/AKT/mTOR pathway was evaluated using western blots. Results: Drug-resistant Klebsiella pneumoniae infection reduced A549 cell viability, promoted apoptosis, and increased TNF-α, IL-6, and IL-1β levels. Meropenem treatment failed to reverse these effects, confirming the drug resistance. TRAIL overexpression exacerbated Klebsiella pneumoniae infection-induced viability inhibition, apoptosis, and inflammation, suggesting that TRAIL enhances the drug resistance of Klebsiella pneumoniae. In contrast, TRAIL knockdown showed the opposite results. TRAIL overexpression upregulated armA expression and activated the PI3K/AKT/mTOR pathway, but armA inhibition reversed TRAIL-mediated drug resistance and PI3K/AKT/mTOR activation. Conclusion: TRAIL-mediated armA upregulation enhanced the drug resistance of Klebsiella pneumoniae by activating the PI3K/AKT/mTOR signaling pathway. These findings provide new insight into the drug resistance mechanisms of Klebsiella pneumoniae.Keywords
This publication has 26 references indexed in Scilit:
- First Report of an Extensively Drug-Resistant ST23 Klebsiella pneumoniae of Capsular Serotype K1 Co-Producing CTX-M-15, OXA-48 and ArmA in SpainAntibiotics, 2021
- Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosidesRevista da Sociedade Brasileira de Medicina Tropical, 2021
- The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniaeInternational Journal of Environmental Research and Public Health, 2020
- Highly multidrug-resistant Morganella morganii clinical isolates from Nepal co-producing NDM-type metallo-β-lactamases and the 16S rRNA methylase ArmAJournal of Medical Microbiology, 2020
- Molecular epidemiology of nonsevere clinical mastitis caused by Klebsiella pneumoniae occurring in cows on 2 Wisconsin dairy farmsJournal of Dairy Science, 2020
- TRAIL encapsulated to polypeptide-crosslinked nanogel exhibits increased anti-inflammatory activities in Klebsiella pneumoniae-induced sepsis treatmentMaterials Science and Engineering: C, 2019
- TRAIL Mediated Signaling in Breast Cancer: Awakening Guardian Angel to Induce Apoptosis and Overcome Drug Resistance2019
- The role of the PI3K/mTOR signaling pathway in Staphylococcus epidermidis small colony variants intracellular survivalImmunological Investigations, 2018
- Emergence of armA and rmtB genes among VIM, NDM, and IMP metallo-β-lactamase-producing multidrug-resistant Gram-negative pathogensActa Microbiologica Et Immunologica Hungarica, 2017
- TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in miceJournal of Experimental Medicine, 2012